5Ho KK, Pinsky JL,Kannel WB, et al . The epidemiology ofchronic heart failure; the Framingham Study [J]. J Am Coll Cardiol ,1993,22(4 Suppl A):6-13A.
6Fischer M,Baessler A, Hense HW, et al . Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a populationsample[J]. Eur Heart J,2003,24(4) :320-328.
7Levine B, Kalman J, Mayer L, et al. Elevated circulation levels of tumor necrosis factor in severe chronic heart failure [J]. N En- gl J Med, 1990,323(4) :236-241.
8Zeng X H, Li Y Y. Proinflammatory cytokines and mortalit in ad- vanced heart failure [J]. Heart Failure, 2002,8(1): 160-162.
9Packer M. Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure?[J]. Circulation, 1995,92(6) : 1379-1382.
10Gealekman J, Abassi Z, Rubinstein I, et al. Role of myocardial inducible nitric oxidesynthase in contractile dysfunction and beta- adrenergic hyporesponsiveness in rats with experimental volume- overload heart failure [J]. Circulation, 2002,105(2); 236-243.
